AMGN
Amgen Inc.
NASDAQ · Healthcare · Drug Manufacturers - General · US
$436.72
−1.67%Forward multiples
Based on analyst estimates
- P/E forward
- 18.62x
- P/E 2026E
- 18.97x
- P/E 2027E
- 17.93x
- P/E 2028E
- 17.04x
- P/S forward
- 5.91x
Trailing multiples
Trailing twelve months
- P/E TTM
- 26.92x
- PEG TTM
- 0.61x
- Price / book
- 20.20x
- Price / sales
- 6.19x
- Price / cash flow
- 18.92x
Enterprise value
- Enterprise value
- $279.4B
- EV / sales
- 7.33x
- EV / EBITDA
- 16.92x
- EV / EBIT
- 22.09x
- Market cap
- $236.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026